Liezl Gambe

Paradigm Biopharmaceuticals (ASX:PAR) appointed Dr Daniel Furtner as chief medical officer, effective Sept. 16.

Australian Rare Earths (ASX:AR3) completed follow-up drilling that extended the Overland carbonatite discovery.

Mayne Pharma (ASX:MYX) secured exclusive five-year Australian rights to commercialise menopause gel Blissel.

Privacy coins have surged as investors rotate into Zcash and Monero while Bitcoin remains below its October 2025 peak.

Bulgaria’s National Assembly has approved amendments giving the National Revenue Agency access to detailed data on crypto-asset users as the country strengthens tax reporting rules.

Immigration talks between the Australian Government and Coalition collapsed after Anthony Albanese and Angus Taylor failed to reach an agreement across two meetings.

Eight US banking groups have urged the Senate to tighten stablecoin reward restrictions in the Clarity Act.

ANZ Group Holdings (ASX:ANZ) reported that iron ore prices are expected to hold steady between US$90 and US$95 a tonne for the remainder of the year.

Johnson & Johnson (NYSE:JNJ) is reportedly in discussions to sell its DePuy Synthes orthopedics business to Apollo Global Management for approximately $20 billion.

Canaan (NASDAQ:CAN) released its August 2026 update, mining 44 Bitcoin and securing US$13.9 million from asset sales.